The Harvard Medical School-based research training program entitled """"""""Infectious Diseases and Basic Microbiological Mechanisms"""""""" offers a minimum of two years of laboratory-based research training for physicians and postdoctoral PhD scientists.
The aim i s to provide substantive research training experience with relevant supporting course work and thereby to enable the postdoctoral trainee to become an independent investigator in the fields of infectious diseases and microbiology. Training laboratories are in nine major areas: (1) bacteriology, including pathogenesis, genetics, toxins, virulence factors, cell biology, host defense, and vaccine development; (2) virology, including pathogenesis, genetics, cell biology, virulence, host defense, antiviral agents, and retrovirology; (3) parasitology, including pathogenesis, chloroquine resistance of malaria, parasite-cell interactions, and host defense; (4) immunology, including complement, T cells, B cells, and regulation of the antibody response; (5) epidemiology, including pharmacoepidemiology and nosocomial infections; (6) cell biology of eosinophils and basophils; (7) biochemistry of proteins, carbohydrates, and lipids; (8) molecular biology and genetics; and (9) biodefense and emerging infectious diseases. The purpose of this renewal application for this T32 grant is the continuation of this highly successful program, which has been supported by the NIH for the past 30 years. During the past five-year period, approximately 248 trainees completed the program. Of these individuals, 175 now hold positions in academia or work in government service. Sixty hold the rank of assistant professor or higher at 52 colleges, universities and medical schools around the world. An additional 36 have taken positions as scientists in industry. Thirteen are identified as practicing physicians many of whom also hold academic appointments. Although only eight positions per year are supported by this grant, 191 postdoctoral trainees are currently being funded by our, training program in the laboratories of the 51 participating research mentors. ? ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
2T32AI007061-31
Application #
7501574
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Peters, Kent
Project Start
1976-07-01
Project End
2013-07-31
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
31
Fiscal Year
2008
Total Cost
$463,208
Indirect Cost
Name
Harvard University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
02115
Mou, Xiangyu; Souter, Skye; Du, Juan et al. (2018) Synthetic bottom-up approach reveals the complex interplay of Shigella effectors in regulation of epithelial cell death. Proc Natl Acad Sci U S A 115:6452-6457
Kanjilal, Sanjat; Sater, Mohamad R Abdul; Thayer, Maile et al. (2018) Trends in Antibiotic Susceptibility in Staphylococcus aureus in Boston, Massachusetts, from 2000 to 2014. J Clin Microbiol 56:
Zheng, Sanduo; Sham, Lok-To; Rubino, Frederick A et al. (2018) Structure and mutagenic analysis of the lipid II flippase MurJ from Escherichia coli. Proc Natl Acad Sci U S A 115:6709-6714
Carey, Allison F; Rock, Jeremy M; Krieger, Inna V et al. (2018) TnSeq of Mycobacterium tuberculosis clinical isolates reveals strain-specific antibiotic liabilities. PLoS Pathog 14:e1006939
Li, Shu Shun; Ogbomo, Henry; Mansour, Michael K et al. (2018) Identification of the fungal ligand triggering cytotoxic PRR-mediated NK cell killing of Cryptococcus and Candida. Nat Commun 9:751
Piantadosi, Anne; Kanjilal, Sanjat; Ganesh, Vijay et al. (2018) Rapid Detection of Powassan Virus in a Patient With Encephalitis by Metagenomic Sequencing. Clin Infect Dis 66:789-792
Truelson, Katherine A; Brennan-Krohn, Thea; Smith, Kenneth P et al. (2018) Evaluation of apramycin activity against methicillin-resistant, methicillin-sensitive, and vancomycin-intermediate Staphylococcus aureus clinical isolates. Diagn Microbiol Infect Dis 92:168-171
Miller, Kelly A; Garza-Mayers, Anna Cristina; Leung, Yiuka et al. (2018) Identification of interactions among host and bacterial proteins and evaluation of their role early during Shigella flexneri infection. Microbiology 164:540-550
Midani, Firas S; Weil, Ana A; Chowdhury, Fahima et al. (2018) Human Gut Microbiota Predicts Susceptibility to Vibrio cholerae Infection. J Infect Dis 218:645-653
Bourque, Daniel L; Bhuiyan, Taufiqur Rahman; Genereux, Diane P et al. (2018) Analysis of the Human Mucosal Response to Cholera Reveals Sustained Activation of Innate Immune Signaling Pathways. Infect Immun 86:

Showing the most recent 10 out of 284 publications